Evogene Chairman Nir Nimrodi Resigns Board Seat
EVGN sits 46% above its 52-week low of $0.25.
Summary
Evogene's chairman Nir Nimrodi resigned from the board on November 13, 2026, with no disagreement cited and no replacement named. It is the latest board departure at a company already dealing with a Nasdaq bid-price deficiency and a recently settled activist fight.
Key Events · Executive and Board Changes · EVGN
-
Chairman Resigns Board
Nir Nimrodi notified the board on November 13, 2026 of his resignation as a member and chairman of the board of directors.
-
No Disagreement Cited
The filing states the resignation was not related to any disagreement with the Company on operations, policies or practices.
-
No Successor Named
The 6-K does not identify an interim or permanent chairman, leaving the board's leadership slot open.
-
Follows Recent Board Turnover
Directors Yoshinori Oikawa and Yael Margolin resigned on September 9, 2026, and the board was reconstituted under the October 6, 2026 cooperation agreement with Pure Capital.
Analysis · EVGN · Industrial Applications And Services
The chairman of the board is gone, and the filing names no successor, leaving a board that was only just reconstituted under the October 6 cooperation agreement with Pure Capital. This comes weeks after two directors resigned on September 9 and a proxy fight ended in a settlement, marking a second wave of board turnover at a company already fighting a Nasdaq minimum-bid deficiency and burning cash. The filing says the departure is not over any disagreement, but a chairman exit at this juncture removes continuity exactly when the board is supposed to be overseeing the activist-backed reset.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EVGN was trading at $0.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.7M. The 52-week trading range was $0.25 to $1.26. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.